Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Liraglutide (Primary) ; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIRA-Ramadan
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 06 Jun 2015 Results from this study presented on 06 June 2015 at the 75th Annual Scientific Sessions of the American Diabetes Association in Boston, MA, USA.
- 06 Jun 2015 Results from this study published in a Novo Nordisk Media Release.